| pubmed-article:6145289 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6145289 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:6145289 | lifeskim:mentions | umls-concept:C0001645 | lld:lifeskim |
| pubmed-article:6145289 | lifeskim:mentions | umls-concept:C0018811 | lld:lifeskim |
| pubmed-article:6145289 | lifeskim:mentions | umls-concept:C0565599 | lld:lifeskim |
| pubmed-article:6145289 | lifeskim:mentions | umls-concept:C2709058 | lld:lifeskim |
| pubmed-article:6145289 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:6145289 | pubmed:dateCreated | 1984-7-12 | lld:pubmed |
| pubmed-article:6145289 | pubmed:abstractText | The effects of two different beta-adrenergic antagonists on maternal arterial pressure and fetal heart rate were studied in 8 pregnant women with pregnancy hypertension. The fetal heart rate was monitored by abdominal ECG recording under standardized conditions. Basal heart rate, long-term variability and short-term variability were calculated in a computer. Four patients received 50-100 mg atenolol once daily; the other 4 received pindolol 10 mg b.i.d. Reduction in mean arterial blood pressure was seen in both groups of patients. The basal fetal heart rate was decreased in atenolol-exposed fetuses but not in pindolol-exposed fetuses. In this preliminary study there was no apparent effect on the fetal heart rate variability. | lld:pubmed |
| pubmed-article:6145289 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6145289 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145289 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6145289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145289 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6145289 | pubmed:issn | 0300-8835 | lld:pubmed |
| pubmed-article:6145289 | pubmed:author | pubmed-author:MelanderAA | lld:pubmed |
| pubmed-article:6145289 | pubmed:author | pubmed-author:IngemarssonII | lld:pubmed |
| pubmed-article:6145289 | pubmed:author | pubmed-author:WestgrenMM | lld:pubmed |
| pubmed-article:6145289 | pubmed:author | pubmed-author:LiedholmHH | lld:pubmed |
| pubmed-article:6145289 | pubmed:author | pubmed-author:MontagHH | lld:pubmed |
| pubmed-article:6145289 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6145289 | pubmed:volume | 118 | lld:pubmed |
| pubmed-article:6145289 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6145289 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6145289 | pubmed:pagination | 95-7 | lld:pubmed |
| pubmed-article:6145289 | pubmed:dateRevised | 2008-2-21 | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:meshHeading | pubmed-meshheading:6145289-... | lld:pubmed |
| pubmed-article:6145289 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6145289 | pubmed:articleTitle | Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists. A preliminary report. | lld:pubmed |
| pubmed-article:6145289 | pubmed:publicationType | Journal Article | lld:pubmed |
